Another possible cause is the mutational landscape in the murine tumor cells, MDA-F471 cells carry Kras G12D variants, Kras gene amplification and very high somatic mutation burden while the H1792 cell line carries KRAS G12C variant and other co-occurring driver mutations as well as lower somatic mutation burden compared to the murine cell line [48]. This evidence concerns the gene KRAS and neoplasm.